Jupiter Neurosciences, Inc.
JUNS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679628
No open-market purchases or sales by Jupiter Neurosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $826.9K in total; no superinvestor holds it.
Superinvestors holding JUNS, Q2 2026
No superinvestor reported holding JUNS in Q2 2026.